Zeluvalimab
Zeluvalimab (AMG-404) is a monoclonal antibody targeting the PD-1 receptor that can be used for the research of cancer[1].
Product Specifications
CAS Number
[2315361-37-4]
Product Name Alternative
AMG-404
UNSPSC
12352203
Target
PD-1/PD-L1
Type
Inhibitory Antibodies
Related Pathways
Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/zeluvalimab.html
Purity
96.84
Solubility
H2O
Smiles
[Zeluvalimab]
Molecular Weight
(144.15 kDa)
References & Citations
[1]Price T J, et al. 142P Updated results from a phase I, open-label, multicenter, first-in-human study of AMG 404, a checkpoint inhibitor, in patients with advanced solid tumors. Annals of Oncology, 2021, 32: S1440-S1442.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 2
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
C2548-84P6 100 µg
CD40L (CD40 Ligand, CD40-L, T-cell Antigen Gp39, TNF-related Activation Protein, TRAP, Tumor Necrosis Factor Ligand Superfamily Member 5, CD154, CD40LG, TNFSF5, TRAP) discontinued
Ask
View Details 
RC230540L3V 200 µL
CNKSR2 (NM_001168649) Human Tagged ORF Clone Lentiviral Particle
Ask
View Details MBS7065159 Inquire
Recombinant Shewanella baltica Lipoprotein signal peptidase (lspA), partial
Ask
View Details